SNY/TBIO Move COVID-19 Vaccine Into Clinic, AVXL's PDD Study Promising, EIGR On Watch

Today's Daily Dose brings you news about Eiger BioPharma's COVID-19 ILIAD study results, disappointing results of Servier/Galapagos' knee osteoarthritis drug trial, Anavex Life's Parkinson's disease dementia trial, the progress in Sanofi/Translate Bio's COVID-19 vaccine candidate MRT5500, and Lilly loosening its purse strings to bolster its pipeline with SARM1 programs for axonal degeneration.

from RTT - Biotech https://ift.tt/31auo10
via IFTTT